SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Pulmonology Referral — Theodore Roosevelt — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Theodore Roosevelt |
|---|
| Date of birth | 1858-10-27 |
|---|
| Identifiers | MRN HR-NI012-SYN-TD; SSN (made up) 000-12-6157 |
|---|
| Document date | 1882-03-09 |
|---|
| Author | Amos Kettering, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Lifelong asthma in a 23-year-old athlete, uncontrolled on albuterol alone. Please confirm the diagnosis and severity, assess for type 2 inflammation and allergic triggers, and advise on treatment step and exercise. [S]
Urgency: Routine, within four weeks. [S]
Questions for the consultant:
- Do you agree that this is moderate persistent asthma, and is anything else, such as vocal cord dysfunction, contributing?
- Is there evidence of type 2 or allergic inflammation, and which allergen measures are worthwhile?
- Is Step 4 maintenance-and-reliever therapy the right level, and when should we step down?
- How should he manage symptoms during boxing and rowing?
- Is he a candidate for allergen immunotherapy or a biologic now or later?
History of Present Illness
Asthma since early childhood. For several months: symptoms most days, night waking about twice a week, and albuterol use most days; one oral corticosteroid course at urgent care in the winter. Asthma Control Test 13. Spirometry today: FEV1 3.20 L (72 percent predicted), FEV1/FVC 0.67, rising to 3.74 L after bronchodilator (17 percent, 540 mL). Never smoker; no occupational exposure; older carpeted apartment. Boxes, rows, and takes long hill walks. Albuterol was stopped today and budesonide-formoterol maintenance-and-reliever therapy started at two inhalations twice daily plus one as needed [S]
- Wheeze, night cough, and breathlessness are limiting his training and his long days at work. [S]
- Would rather control his asthma with exercise than with daily medicine. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Theodore Roosevelt was born at 28 East 20th Street, New York City, on October 27, 1858. [D]
- In his autobiography Roosevelt wrote that he was a sickly, delicate boy who suffered much from asthma and frequently had to be taken away on trips to find a place where he could breathe; he remembered sitting up in bed gasping at night as a very small child. [D]
- When he was nearly fourteen, during an attack of asthma, he was sent alone to Moosehead Lake; after two other boys on the stage-coach easily overpowered him, he began boxing lessons and a long program of physical training, with his father's approval. [D]
- Roosevelt wrote that he was very near-sighted as a boy without knowing it, and that at about thirteen, after he could not read a distant billboard, he got his first pair of spectacles. [D]
- A 2015 review of the historical record in the Journal of Allergy and Clinical Immunology: In Practice concluded that his respiratory problems began in early childhood, that the record gives strong evidence for poorly controlled persistent asthma, that the asthma became relatively quiet in adolescence when his exercise program began at about 12, and that he continued to have serious exacerbations in adolescence and adulthood; it found little if any support for the claim that his asthma was psychosomatic. [R]
- Roosevelt received his Bachelor of Arts degree from Harvard in June 1880 and was elected to the New York State Assembly in 1881. [D]
- His father, Theodore Roosevelt Sr., died in 1878 shortly after being diagnosed with stomach cancer. [D]
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Albuterol 90 mcg/actuation inhaler, two inhalations as needed for wheeze (bought after an urgent care visit; used most days before intake) | Two inhalations every 4 hours as needed | Respiratory tract route | 1881-12-15 to 1882-03-09 | stopped | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance | Two inhalations twice daily, with a spacer, rinsing the mouth afterwards | Respiratory tract route | 1882-03-09 | active | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total | One inhalation as needed, repeated after a few minutes if needed; maximum 12 inhalations a day including maintenance doses | Respiratory tract route | 1882-03-09 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthma | active | confirmed |
J45.40 | S — Synthetic modern classification confirmed by spirometry; the historical asthma is D and its persistence into adulthood is R. |
| Myopia, both eyes, corrected with glasses since boyhood | active | confirmed |
H52.13 | S — Synthetic modern entry linked to his documented near-sightedness. |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| 1860s | Severe childhood asthma, with night attacks in which he sat up in bed gasping, and trips away from home to find a place where he could breathe | D (CLM-0002) |
| 1872 | Near-sightedness discovered at about thirteen; first spectacles | D (CLM-0004) |
| 1872 | Asthma attack at nearly fourteen, after which he was sent to Moosehead Lake and began boxing and a program of physical training | D (CLM-0003) |
Family History
| Relative | Condition | Age at death | Evidence |
|---|
| father | Died in 1878, shortly after a diagnosis of stomach cancer | | D (CLM-0007) |
Social History
- Occupation: first-term state legislator, also writing a naval history; long days in session and frequent public speaking [S]
- Never smoker; does not vape; drinks alcohol rarely; no drug use [S]
- Exercise: boxes three times a week, rows, and takes long hill walks most weekends; believes hard training is what controls his asthma [S]
- Lives in an older city apartment with wall-to-wall carpet; no pets; no visible mold; no workplace fumes or dusts [S]
- Supports: close friends, a boxing coach, and colleagues at work [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1882-03-09 | Body height | 175 | cm | S |
| 1882-03-09 | Body weight | 72 | kg | S |
| 1882-03-09 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1882-03-09 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1882-03-09 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1882-03-09 | Heart rate | 84 | /min | S |
| 1882-03-09 | Respiratory rate | 18 | /min | S |
| 1882-03-09 | Body temperature | 36.8 | Cel | S |
| 1882-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1882-03-09 | FEV1 --pre bronchodilation | 3.2 | L | >=3.65 L | Low | S |
| 1882-03-09 | FEV1 measured/predicted | 72 | % | >=80% | Low | S |
| 1882-03-09 | Forced vital capacity [Volume] Respiratory system | 4.8 | L | >=4.4 L | Normal | S |
| 1882-03-09 | FEV1/FVC | 0.67 | {ratio} | >=0.72 | Low | S |
| 1882-03-09 | FEV1 --post bronchodilation | 3.74 | L | >=3.65 L | Normal | S |
| 1882-03-09 | Total score [ACT] | 13 | {score} | | | S |
| 1882-03-09 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | | | S |
Assessment
- Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthma: active, confirmed [S]
- Myopia, both eyes, corrected with glasses since boyhood: active, confirmed [S]
Plan of Treatment
- Stop reliever-only albuterol and start budesonide-formoterol maintenance-and-reliever therapy at Step 4 (two inhalations twice daily plus one as needed, up to 12 a day), with a spacer and inhaler-technique teaching. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020) [S]
- Written asthma action plan with symptom and peak-flow zones (green 80 percent or more of personal best, yellow 50 to 79 percent, red below 50 percent), reviewed at every visit and after every exacerbation. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026) [S]
- Asthma Control Test, inhaler technique, adherence, reliever use, triggers, and exacerbation history at every visit; review one to three months after starting controller therapy, then every three to twelve months, and within one week of any exacerbation; spirometry at diagnosis, three to six months after stabilization, then every one to two years. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026) [S]
- Explain that exercise improves fitness but does not treat airway inflammation; take one reliever inhalation before boxing or rowing; use dust-mite-impermeable bedding covers once sensitization is shown. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020) [S]
- Yearly influenza vaccine, pneumococcal vaccination for chronic lung disease, and COVID-19 vaccination by CDC guidance. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026); Summary of Risk-based Pneumococcal Vaccination Recommendations (2025) [S]
- Referral to pulmonology, Noor Haddad, MD, ordered 1882-03-09 [S]